May 9 |
Natera GAAP EPS of -$0.56 beats by $0.16, revenue of $367.74M beats by $52.41M
|
May 9 |
Natera Reports First Quarter 2024 Financial Results
|
May 9 |
How Is The Market Feeling About Natera?
|
May 8 |
Natera Q1 2024 Earnings Preview
|
May 3 |
New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer
|
May 2 |
Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
|
May 2 |
Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
|
May 1 |
Natera to Report its First Quarter 2024 Results on May 9
|
May 1 |
Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage
|
Apr 27 |
Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc
|